Navigation Links
Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART
Date:7/31/2014

San Diego, CA (PRWEB) July 31, 2014

Rancho BioSciences, the scientific data consulting company announced today the integration of Omicsoft’s Array Suite with tranSMART. Scientists that have access to both platforms will be able to send data in tranSMART to Array Suite for further analysis. The integration works with all versions of tranSMART including the new 1.2 release. Array Suite provides state of the art statistics, visualization and storage for the analysis of high dimensional quantification data, including expression, CNV/CGH data, Genotyping data, and more.

“When we manually curate data for our customers they often ask us to make it ready to load in to tranSMART and Array Suite”, said Julie Bryant, CEO. “We wanted to make this process easier for them so we integrated Array Suite with tranSMART. We plan to provide additional integration solutions for our customers in the future.”

“Having the ability to store data in both Array Suite and tranSMART is a real benefit to our customers”, said Jack Liu, President. “We understand the value of publicly available tools like tranSMART, and want to provide interoperability so that our customers can take advantage of both tranSMART and our fantastic analytics, visualizations, and storage options.”

About Rancho BioSciences
Rancho BioSciences is a fee-for-service data-curation consulting company leveraging open-source tools and public-domain data. Our customers include Pharma, Institutes, and Academics.

We have a team of experienced Ph.D. and M.D. scientists around the world that deliver high quality work based on their expertise and domain knowledge in biology, diseases, and clinical data. Rancho BioSciences is flexible and cost effective, providing on site and off site curators.

Rancho BioSciences also has expertise in databases and hosts or installs tranSMART for their customers.

Our goal is to help the life-science community build better tools and take advantage of a wealth of scientific data by supporting and developing open source platforms.

For more information about Rancho BioSciences, please visit us online at http://www.ranchobiosciences.com.

About Omicsoft Corporation
At Omicsoft, we focus on biomarker data management, visualization, and analysis. To achieve this, we need to design software that is easy to use for the bench scientists, but powerful enough to be used by the bioinformatician or statistician. Our products are designed with the influence of all three groups, and thus are fast, powerful, and easy to use.

Array Suite (Array Studio and Array Server) provides our customers with world-class visualizations, storage, and analysis for all types of OMIC and NextGeneration Sequencing data.

Omicsoft also offers data services that integration with Array Suite, including OncoLand (http://www.omicsoft.com/oncoland-service/). From the clinic to the lab, OncoLand allows the user to incorporate public and private data spanning clinical and in vitro datasets.
For more information about Omicsoft Corporation, please visit us online at http://www.omicsoft.com

Read the full story at http://www.prweb.com/releases/2014/07/prweb12057832.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Rancho BioSciences Will Present the Accelerated Cure Project Multiple Sclerosis Data Curation White Paper at the tranSMART Fall Developers Meeting, Paris, November 5-7
2. Rancho BioSciences will present the tranSMART open source platform at TM Forum’s Digital Disruption 2013, Oct 28-31, San Jose
3. Rancho BioSciences Partners with OmicSoft for Manual Data Curation
4. Rancho BioSciences Launches Rancho tranSMART Hosted for Clinical and Genomic Data Storage and Analysis
5. Microvi and Aquatech Break Ground on Large Demonstration System at Aerojet Site in Rancho Cordova, CA
6. Cardio3 BioSciences, a European biopharmaceutical company, now covered by Edison Investment Research
7. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
8. Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
9. Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors
10. Regado Biosciences, Inc. to Provide Third Quarter 2013 Financial Results
11. Jeeven BioSciences, Inc. Announces the Release of Its Neuro-XTM Serum-Free and Xeno-Free Tissue Culture Media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... ... World Congress Center in Atlanta, Georgia, will include 848 exhibitors (count as of ... will be displaying products and services used by the scientific community in industrial, ...
(Date:2/11/2016)... Non-profit Consortium Aims to Generate Genomic Information for ... Discovery --> --> The ... sequence 100,000 individuals. It is intended to initially include populations ... North and East Asian countries. --> ... focus on creating phased reference genomes for all major Asian ...
(Date:2/11/2016)... Feb. 11, 2016  Bioethics International, a not-for-profit organization focused ... developed, marketed and made accessible to patients around the world, ... had named the publication of the Good Pharma Scorecard ... is also featured as one of BMJ Open ,s ... year that are most frequently read. Ed Sucksmith ...
(Date:2/11/2016)...  Dovetail Genomics™ LLC today announced that it has ... planned metagenomic genome assembly service. Richard Green , ... method in a talk on Friday, February 12 at ... in Orlando, Fla. ... difficult. Using its proprietary Chicago ™ ...
Breaking Biology Technology:
(Date:2/3/2016)... , Feb. 3, 2016 Vigilant Solutions ... Police Department in Missouri solved ... plate reader (LPR) data from Vigilant Solutions. ... case in which the victim was walking out of a convenience store and ... space next to his vehicle, striking his vehicle and ...
(Date:2/2/2016)... 2016 Checkpoint Inhibitors for Cancer – ... Are you interested in the future of cancer ... inhibitors. Visiongain,s report gives those predictions to 2026 ... level. Avoid falling behind in data or ... revenues those emerging cancer therapies can achieve. There ...
(Date:2/1/2016)... 1, 2016 Rising sales of ... global touchfree intuitive gesture control market size ... sales of consumer electronics coupled with new technological advancements ... size through 2020   --> ... new technological advancements to drive global touchfree intuitive gesture ...
Breaking Biology News(10 mins):